https://www.newmediawire.com/news/fluence-energy-inc-flnc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-kessler-topaz-meltzer-check-llp-7091168 2026-11-09 NewMediaWire en 2026-11-09 Fluence Energy, Inc. (FLNC) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP https://www.newmediawire.com/news/community-cpr-and-ems-intervention-program-did-not-increase-survival-after-cardiac-arrest-7091167 2026-11-08 NewMediaWire en 2026-11-08 Community CPR and EMS Intervention Program Did Not Increase Survival After Cardiac Arrest https://www.newmediawire.com/news/blood-pressure-medication-combo-linked-to-fewer-irregular-heart-rhythms-after-ablation-7091166 2026-11-08 NewMediaWire en 2026-11-08 Blood Pressure Medication Combo Linked to Fewer Irregular Heart Rhythms After Ablation https://www.newmediawire.com/news/novel-pacemaker-technique-reduced-cardiac-events-in-people-with-a-heart-rhythm-disorder-7091165 2026-11-08 NewMediaWire en 2026-11-08 Novel Pacemaker Technique Reduced Cardiac Events In People With a Heart Rhythm Disorder https://www.newmediawire.com/news/new-national-initiative-will-advance-science-deepen-understanding-of-heart-brain-connection-7091164 2026-11-08 NewMediaWire en 2026-11-08 New National Initiative Will Advance Science, Deepen Understanding of Heart-Brain Connection https://www.newmediawire.com/news/balloon-technique-may-help-improve-circulation-to-heart-and-brain-during-cardiac-arrest-7091163 2026-11-07 NewMediaWire en 2026-11-07 Balloon technique may help improve circulation to heart and brain during cardiac arrest https://www.newmediawire.com/news/yoga-based-cardiac-rehab-improved-quality-of-life-in-people-living-with-heart-failure-7091162 2026-11-07 NewMediaWire en 2026-11-07 Yoga-based Cardiac Rehab Improved Quality of Life In People Living With Heart Failure https://www.newmediawire.com/news/phone-app-alerts-did-not-increase-bystander-cpr-rates-in-study-of-2-major-population-areas-7091161 2026-11-07 NewMediaWire en 2026-11-07 Phone App Alerts Did Not Increase Bystander CPR Rates In Study of 2 Major Population Areas https://www.newmediawire.com/news/intensive-blood-pressure-therapy-did-not-cut-cardiovascular-events-in-adults-with-diabetes-7091160 2026-11-07 NewMediaWire en 2026-11-07 Intensive Blood Pressure Therapy Did Not Cut Cardiovascular Events In Adults With Diabetes https://www.newmediawire.com/news/discontinuing-statins-generally-safe-for-older-adults-without-heart-disease-7091159 2026-11-07 NewMediaWire en 2026-11-07 Discontinuing Statins Generally Safe for Older Adults Without Heart Disease https://www.newmediawire.com/news/selective-smartphone-alerts-helped-improve-bystander-response-time-for-cardiac-arrest-7091158 2026-11-07 NewMediaWire en 2026-11-07 Selective Smartphone Alerts Helped Improve Bystander Response Time for Cardiac Arrest https://www.newmediawire.com/news/intensive-blood-pressure-control-in-stroke-survivors-lowered-risk-of-cardiovascular-events-7091157 2026-11-07 NewMediaWire en 2026-11-07 Intensive Blood Pressure Control in Stroke Survivors Lowered Risk of Cardiovascular Events https://www.newmediawire.com/news/can-a-low-cost-diuretic-medication-help-to-lower-blood-pressure-after-a-stroke-7091156 2026-11-07 NewMediaWire en 2026-11-07 Can A Low-Cost Diuretic Medication Help To Lower Blood Pressure After A Stroke? https://www.newmediawire.com/news/lp-a-horizon-trial-lp-a-fell-by-78-but-cardiovascular-outcomes-unexpectedly-neutral-7091155 2026-11-07 NewMediaWire en 2026-11-07 Lp(a) HORIZON Trial: Lp(a) Fell By 78%, But Cardiovascular Outcomes Unexpectedly Neutral https://www.newmediawire.com/news/gildan-activewear-inc-gil-investor-alert-gil-stock-drops-further-amid-poor-q3-earnings-december-14-2026-deadline-contact-kessler-topaz-meltzer-check-llp-7091154 2026-11-07 NewMediaWire en 2026-11-07 Gildan Activewear Inc. (GIL) Investor Alert: GIL Stock Drops Further Amid Poor Q3 Earnings; December 14, 2026 Deadline - Contact Kessler Topaz Meltzer & Check, LLP https://www.newmediawire.com/news/researchers-say-inflammation-as-a-treatment-target-still-important-despite-neutral-results-of-zeus-trial-7091153 2026-11-07 NewMediaWire en 2026-11-07 Researchers say inflammation as a treatment target still important despite neutral results of ZEUS trial